Related Experiment Video
Updated: Jul 31, 2026
09:35
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Leptin effects on pancreatic beta-cell gene expression and function
1Division of Metabolism, Medizinische Poliklinik, University of Wuerzburg, Wuerzburg, Germany. j.seufert@mail.uni-wuerzburg.de
Diabetes
|January 30, 2004
Summary
Leptin regulates appetite and energy. In pancreatic beta-cells, leptin restrains insulin production and secretion, impacting glucose homeostasis. Leptin resistance in these cells may drive type 2 diabetes.
Area of Science:
- Endocrinology
- Metabolic Research
- Molecular Biology
Background:
- Leptin, a hormone from white adipocytes, correlates with adipose tissue mass and regulates satiety and energy expenditure via hypothalamic leptin receptors (ObR).
- Leptin also exerts peripheral actions, notably inhibiting insulin biosynthesis and secretion in pancreatic beta-cells, forming the adipo-insular axis with insulin.
- Dysregulation of this axis is implicated in metabolic disorders.
Purpose of the Study:
- To investigate the molecular mechanisms of leptin signaling in pancreatic beta-cells.
- To identify genes regulated by leptin in these cells.
- To explore the role of leptin resistance in the adipo-insular axis and type 2 diabetes development.
Main Methods:
- Analysis of leptin's effects on gene expression in pancreatic beta-cells.
- Identification of leptin-repressed and leptin-induced genes.
- Examination of signal transduction pathways involved in leptin action.
Main Results:
- Identified proinsulin and protein phosphatase 1 genes as leptin-repressed.
- Identified the suppressor of cytokine signaling 3 protein gene as leptin-induced.
- Leptin's molecular effects restrict insulin secretion and biosynthesis, adapting glucose homeostasis to body fat levels.
Conclusions:
- Leptin plays a crucial role in regulating insulin homeostasis through specific gene expression changes in pancreatic beta-cells.
- Leptin resistance in beta-cells may disrupt the adipo-insular axis.
- This disruption contributes to hyperinsulinemia and type 2 diabetes in overweight individuals.
More Related Videos
Related Concept Videos
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.